FEB 11 2003
SMDA_ 510(k) Summary of Safety and Effectiveness
KO21¢ SQ
This summary of safety and effectiveness information is being submitted in accordance with the
requirements of SMDA 1990 and 21 CFR Part 807 subpart E, Section 807.92.
A. Sponsor /Manufacturer Name and Address
1. Applicant / :
Olympus Optical Co., Ltd.
2-3-1 Shinjuku Monolis Nishi-shinjuku
Shinjuku-ku, Tokyo, Japan, 163-0914
Establishment registration number : 8010047
2. Initial !mporter
Olympus America Inc.
Two Corporate Center Drive
Melville, NY 11747-3157
E stablishment registration number : 2429304
3. Contact Person
Laura Storms-Tyler
Director, Regulatory Affairs
Olympus America Inc.
Two Corporate Center Drive
Melville, NY 11747-3157
Tel 631-844-5688
Fax 631-844-5416
B. Device Name, Common Name
1. Common/Usual Name
Electrosurgical Unit and its ancillary equipment.
2. Device Name
Olympus PSD-20 Electrosurgical System and its associated accessories .
3. Classification
21 CFR 876.4300 Endoscopic electrosurgical unit and accessories,
Class I
C. Identification of the predicate or legally marketed device
The following devices are substantially equivalent devices in consideration to its
characteristics or specifications.
Olympus PSD-20 Electrosurgical K970797 Olympus Optical Co., Ltd.
Unit and its associated accessories
(For GI application )
D. Device Description
1. Summary

This instrument has been designed to be used with Olympus recommended Electrosurgical
accessories, Endoscope, Light Source and other ancillary equipment for bronchial endoscopic
treatment (cutting and coagulating.

Recommended endoscopes for this instrument are Olympus’s series BF series, and
Olympus's electrosurgical instruments such as electrosurgical snare, hot biopsy forceps.
Other Olympus electrosurgical devices or instruments can be used with this subject device.
Be sure to check compatibility for each device in each instrument's instruction manual.

The PSD-20 unit offers Monopolar output modes; 5 Cut modes (PURE, BLEND 1/2/3/4),

1 Coagulation mode, (NORMAL COAGULATION), It offers several features to ensure the
safe operation of the unit. For example, the voltage output level setting and a monitor circuit
detect irregularity or improper connections.

2. Design
This device has been designed to be comply with the following voluntary standards.
' + (EC 60601-1
*1EC 60601-2-2
* IEC 60601-2-18
IEC 60601-1-2 (EMC)
3. Materials
There aren't any patient contacting material in PSD-20 itself. Some ancillary equipment
have patient contact materials, however there are no new patient contacting material in
those devices.
4. Technology
This device does not have any special technology or characteristic i.e. this device
is intended to provide electrical power to accessories (such as biopsy) via the use
of high frequency electrical current waveform passing into the tissue during endoscopic
bronchial treatment.
E. Indication for Use
This instrument has been designed to be used with Olympus recommended Electrosurgical
accessories, Endoscope, Light Source and other ancillary equipment for bronchial
endoscopic treatment (cutting and coagulating) including:
- Hemostasis of superficial bleeding
- Treatment of benign tumors like papillomatosis, granulomas, polyps,
lipomas and hemangiomas in the trachea and bronchi

- Recanalization of malignant stenoses

- Treatment of Cicatricial stenoses of the respiratory tract

mig
e Le DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
“rea Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
FEB 11 2003

Olympus Optical Co., Ltd.
c/o Ms. Laura Storms-Tyler
Director, Regulatory Affairs
Olympus America, Inc.
Two Corporate Center Drive
Melville, New York 11747-3157
Re: K021852

Trade/Device Name: Olympus PSD-20 Electrosurgical System and

Its Associated Accessories

Regulation Number: 21 CFR 878.4400 ,

Regulation Name: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: II

Product Code: GEI

Dated: November 12, 2002

Received: November 13, 2002
Dear Ms. Storms-Tyler:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and

/ adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - o Ms. Laura Storms-Tyler
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the
promotion and advertising of your device, please contact the Office of Compliance at (301) 5944639. Also, please note the regulation entitled, "Misbranding by reference to premarket
/ notification” (21CFR Part 807.97) you may obtain. Other general information on your

responsibilities under the Act may be obtained from the Division of Small Manufacturers,
International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597
or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Niwam C Kreveat

frCelia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

ett ATA LITO ERIE AT lm
Indication for Use Statement
: 7
510(k) Number(if known): _Netassiqnedyet- KO QI SS 2
Device Name: Olympus PSD-20 Electrosurgical System and its associated
accessories
Indications for Use :
This instrument has been designed to be used with Olympus recommended
Electrosurgical accessories, Endoscope, Light Source and other ancillary equipment
for bronchial endoscopic treatment (cutting and coagulating) including:
- Hemostasis of superficial bleeding
- Treatment of benign tumors like papillomatosis, granulomas, polyps, lipomas and
hemangiomas in the trachea and bronchi
- Recanalization of malignant stenoses
- Treatment of Cicatricial stenoses of the respiratory tract
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
/ Prescription Use V OR Over-The-Counter Use
(Prescription 21 CFR 801.109)
Meru’ C. Pheve2t— (Optional Format 1-2-96)

(Wivision Sign-Off)

Division of General, Restorative

and Neurological Devices

516(k) Number_/S 62 /§ S2—

